Drug discovery biotech Insilico Medicine has announced a partnership with automated drug discovery platform Arctoris, using artificial intelligence (AI) to identify potential Covid-19 treatments.
They have utilised their technologies to discover, synthesise and profile a set of inhibitors for Covid-19 treatment. Insilico identified novel small molecules using its AI capabilities, with Arctoris rapidly evaluating the intended biological actions on its robotic platform. This has enabled them to profile a set of potent inhibitors that can help patients by modulating the life-threatening cytokine storm caused by Covid-19.
Go deeper with GlobalData
Arctoris co-founder and CEO Martin-Immanuel Bittner said: “During the Covid-19 pandemic, time is of the essence, and this project demonstrates that together, we are able to accelerate the drug discovery process, and create and progress new drug candidates faster and cheaper.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
